VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma

Aida Jlassi, Rim Rejaibi, Maroua Manai, Ghada Sahraoui, Fatma Zahra Guerfali, Lamia Charfi, Amel Mezlini, Mohamed Manai, Karima Mrad, Raoudha Doghri

Open source

DOI: 10.3389/fonc.2024.1352053
Published: 2024-04-03
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2024.1352053,
  title = {VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma},
  author = {Aida Jlassi and Rim Rejaibi and Maroua Manai and Ghada Sahraoui and Fatma Zahra Guerfali and Lamia Charfi and Amel Mezlini and Mohamed Manai and Karima Mrad and Raoudha Doghri},
  year = {2024},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2024.1352053},
  url = {https://doi.org/10.3389/fonc.2024.1352053}
}

RIS

TY  - JOUR
TI  - VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma
AU  - Aida Jlassi
AU  - Rim Rejaibi
AU  - Maroua Manai
AU  - Ghada Sahraoui
AU  - Fatma Zahra Guerfali
AU  - Lamia Charfi
AU  - Amel Mezlini
AU  - Mohamed Manai
AU  - Karima Mrad
AU  - Raoudha Doghri
PY  - 2024
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2024.1352053
UR  - https://doi.org/10.3389/fonc.2024.1352053
ER  -

APA

Jlassi, A., Rejaibi, R., Manai, M., Sahraoui, G., Guerfali, F. Z., Charfi, L., Mezlini, A., Manai, M., Mrad, K., & Doghri, R. (2024). VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma. Frontiers in Oncology. https://doi.org/10.3389/fonc.2024.1352053

Source records

crossref · retrieved 2026-11-11T02:07:55.213Z